HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
BOSTON, March 28, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial ...
ICLR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ICON PLC Investors Have Opportunity to Lead Class Action Lawsuit!
NEW YORK, NY / ACCESS Newswire / March 28, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...